- Volatility till December 31, 2026: Wild volatility could continue, with a possible sell-on-rise mood. Periods of uncertainty, fear and headline-driven moves may continue to test investor patience. The focus should remain on discipline, patience and perseverance rather than short-term market timing. Focus only on a select group of companies that are likely to report better Q2 results.
- As per a market veteran: Macro challenges persist as yields and oil prices rise, and the market could remain range-bound for a few more months. Several categories have outperformed, with select defence, manufacturing, pharma and chemical stocks continuing to show strength.
- RBI policy on 7th October 2026: Market grapevine expects a possible 0.25% rate hike. Stay light and cautious; when conditions are unfavourable, capital protection should take priority over returns.
- GDP growth forecasts are turning positive: Fitch, S&P and Moody’s have raised India’s FY27 growth projections towards 7%. BofA has turned constructive on Indian equities, while other market strategists see potential for a stronger Nifty by late 2026/early 2027. Yet the market continues to struggle for direction amid high valuations, inflation, rising rates and global uncertainties. Whether the worst phase is over remains to be seen.
- Huge negative for Indian economy, bulls and equity/mutual fund investors: India’s crude import bill rose 48% to $74.8 billion in April-August as global oil prices surged. Meanwhile, 74 thermal power plants had critically low coal stocks as of 19th September. Higher energy costs could pressure inflation, the rupee and markets, while rising rates may shift investor preference towards debt funds and bank FDs.
